Literature DB >> 34172633

The Association Between Intraocular Pressure and Visual Field Worsening in Treated Glaucoma Patients.

Jithin Yohannan1, Michael V Boland, Pradeep Ramulu.   

Abstract

PRECIS: In treated eyes with mild/suspect glaucoma, intraocular pressure (IOP) increments are associated with worsening mean deviation (MD) once IOP reaches the 20s. In moderate/advanced eyes, IOP increments are associated with worse visual field (VF) performance across the entire IOP range.
PURPOSE: The purpose of this study was to describe the relationship between mean treated IOP and VF worsening and understand how this relationship is affected by glaucoma severity and IOP range.
METHODS: A total of 1446 eyes of 869 treated glaucoma patients with at least 5 longitudinal reliable VF tests and IOP measures were included. Mixed-effects linear models were employed to understand the effect of eye-specific mean treated IOP on MD slope. Models included interaction terms to assess the differing relationships between MD slope and mean IOP by glaucoma severity (suspect/mild vs. moderate/advanced) and splines to account for the differing effects of mean IOP on MD slope at different IOP ranges (above or below 21 mm Hg).
RESULTS: In suspect/mild glaucoma, when treated IOP values were <21 mm Hg, a 1 mm Hg increment in IOP was not associated with an increase in the rate of VF worsening (P>0.05) but when treated IOP values rose >21 mm Hg, a 1 mm Hg increment in IOP was associated with faster VF worsening (-0.09 dB/y per 1 mm Hg increment, P<0.05). In moderate/advanced disease, a 1 mm Hg increment in treated IOP was associated with faster VF worsening both below and above 21 mm Hg, but the effect was much more pronounced in the higher range (-0.02 dB/y per mm Hg increment <21 mm Hg vs. -0.74 dB/y per mm Hg increment >21 mm Hg, P<0.05 for both).
CONCLUSION: IOP remained associated with VF worsening in eyes with more advanced glaucoma throughout the IOP range but was only associated with VF worsening in eyes with less severe glaucoma at higher IOP.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34172633      PMCID: PMC8797543          DOI: 10.1097/IJG.0000000000001906

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.290


  41 in total

1.  Long-term intraocular pressure fluctuation and visual field progression in glaucoma patients with low intraocular pressure after post-trabeculectomy phacoemulsification.

Authors:  Samin Hong; Chan Yun Kim; Gong Je Seong
Journal:  J Ocul Pharmacol Ther       Date:  2007-12       Impact factor: 2.671

2.  Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye.

Authors: 
Journal:  Can J Ophthalmol       Date:  2009       Impact factor: 1.882

3.  Five-year treatment outcomes in the Ahmed Baerveldt comparison study.

Authors:  Donald L Budenz; Keith Barton; Steven J Gedde; William J Feuer; Joyce Schiffman; Vital P Costa; David G Godfrey; Yvonne M Buys
Journal:  Ophthalmology       Date:  2014-10-17       Impact factor: 12.079

4.  Impact of intraocular pressure reduction on visual field progression in normal-tension glaucoma followed up over 15 years.

Authors:  Shinya Oie; Kyoko Ishida; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2017-05-26       Impact factor: 2.447

5.  Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma.

Authors:  M Araie; M Sekine; Y Suzuki; N Koseki
Journal:  Ophthalmology       Date:  1994-08       Impact factor: 12.079

6.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.

Authors:  Stefano Miglior; Norbert Pfeiffer; Valter Torri; Thierry Zeyen; Jose Cunha-Vaz; Ingrid Adamsons
Journal:  Ophthalmology       Date:  2006-10-27       Impact factor: 12.079

8.  Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.

Authors:  Balwantray C Chauhan; Frederick S Mikelberg; A Gordon Balaszi; Raymond P LeBlanc; Mark R Lesk; Graham E Trope
Journal:  Arch Ophthalmol       Date:  2008-08

9.  Impact of intraocular pressure after filtration surgery on visual field progression in primary open-angle glaucoma.

Authors:  C Lazaro; J Garcia-Feijoo; A Castillo; J Perea; J M Martinez-Casa; J Garcia-Sanchez
Journal:  Eur J Ophthalmol       Date:  2007 May-Jun       Impact factor: 2.597

10.  Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.

Authors:  Gus Gazzard; Evgenia Konstantakopoulou; David Garway-Heath; Anurag Garg; Victoria Vickerstaff; Rachael Hunter; Gareth Ambler; Catey Bunce; Richard Wormald; Neil Nathwani; Keith Barton; Gary Rubin; Marta Buszewicz
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.